Glenmark Pharmaceuticals
↗Mumbai, India
Glenmark Pharmaceuticals is a global, research-led pharmaceutical company with a presence across generics, specialty, and OTC businesses. The company operates in over 80 countries and maintains 14 manufacturing facilities across India, the USA, Argentina, and the Czech Republic.
Glenmark focuses on three key therapeutic areas: Dermatology, Respiratory, and Oncology. Through its innovation arm, Ichnos Glenmark Innovation (IGI), the company is advancing a pipeline of novel biologics, including trispecific antibodies for oncology. In 2024-2025, the company has focused on deleveraging its balance sheet and expanding its specialty portfolio in North America and Europe.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty & Generic Therapeutics
SIZE & FINANCIALS
Employees:10000+
Revenue:$1.5B-$2.0B
Founded:1977
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Public Shareholders, Saldanha Family (Promoters)
STOCK
Exchange:NSE / BSE
Ticker:GLENMARK
Market Cap:$6.6B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Ryaltris)
Modalities:Small molecule, mAb, Trispecific antibodies, Topical formulations, Inhalers
Active Trials:25
Trial Phases:Phase 1: 5 | Phase 2: 8 | Phase 3: 4 | Phase 4: 8
FDA Approvals:150
EMA Approvals:45
CORPORATE STRUCTURE
Subsidiaries:Glenmark Pharmaceuticals Inc. USA, Ichnos Glenmark Innovation (IGI), Glenmark Pharmaceuticals Perú S.A., Glenmark Consumer Care Limited
Key Partnerships:Pfizer (Commercialization of Jabryus), Hikma (Ryaltris US distribution), Menarini (Ryaltris Europe distribution)
COMPETITION
Position:Leader
Competitors:Sun Pharma, Dr. Reddy's Laboratories, Cipla, Lupin, Viatris
LEADERSHIP
Key Executives:
Glenn Saldanha - Chairman & Managing Director
Anurag Mantri - Executive Director & Global CFO
Marc T. Kikuchi - President - North America
Scientific Founders:Gracias Saldanha
Board Members:Cherylann Pinto, Pradeep Kumar Sinha, Saira Ramasastry
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Glenmark Pharmaceuticals and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Glenmark Pharmaceuticals. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.